| 000 | 01723 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250516081106.0 | ||
| 264 | 0 | _c20120629 | |
| 008 | 201206s 0 0 eng d | ||
| 022 | _a1660-3397 | ||
| 024 | 7 |
_a10.3390/md10010242 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLiu, Cheng-Ling | |
| 245 | 0 | 0 |
_aFucoxanthin attenuates rifampin-induced cytochrome P450 3A4 (CYP3A4) and multiple drug resistance 1 (MDR1) gene expression through pregnane X receptor (PXR)-mediated pathways in human hepatoma HepG2 and colon adenocarcinoma LS174T cells. _h[electronic resource] |
| 260 |
_bMarine drugs _cJan 2012 |
||
| 300 |
_a242-257 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aATP Binding Cassette Transporter, Subfamily B |
| 650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xgenetics |
| 650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aColonic Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aConstitutive Androstane Receptor |
| 650 | 0 | 4 |
_aCytochrome P-450 CYP3A _xgenetics |
| 650 | 0 | 4 | _aHep G2 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPregnane X Receptor |
| 650 | 0 | 4 | _aPromoter Regions, Genetic |
| 650 | 0 | 4 |
_aRNA, Messenger _xanalysis |
| 650 | 0 | 4 |
_aReceptors, Cytoplasmic and Nuclear _xphysiology |
| 650 | 0 | 4 |
_aReceptors, Steroid _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aRifampin _xpharmacology |
| 650 | 0 | 4 | _aTranscriptional Activation |
| 650 | 0 | 4 |
_aXanthophylls _xpharmacology |
| 700 | 1 | _aLim, Yun-Ping | |
| 700 | 1 | _aHu, Miao-Lin | |
| 773 | 0 |
_tMarine drugs _gvol. 10 _gno. 1 _gp. 242-257 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3390/md10010242 _zAvailable from publisher's website |
| 999 |
_c21572314 _d21572314 |
||